Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 6Recruiting 3Active not recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Operable Breast Cancer 1Neoplasms 1Breast Neoplasms 1Agnosia 1

Interventions

Paclitaxel 83Fulvestrant 65Trastuzumab 62Letrozole 61pembrolizumab 53Carboplatin 51Cyclophosphamide 48pertuzumab 46palbociclib 44Anastrozole 41Capecitabine 33Tamoxifen 30Magnetic Resonance Spectroscopy 29exemestane 28Radiotherapy 28Doxorubicin 28ribociclib 26olaparib 26Docetaxel 26Specimen Handling 25abemaciclib 24130-nm albumin-bound paclitaxel 20trastuzumab deruxtecan 19Taxes 19Gemcitabine 19durvalumab 18Surveys and Questionnaires 18Epirubicin 18eribulin 17Alpelisib 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Lidocaine × Breast × Clear all
NCT01916317 2025-04-09

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Tata Memorial Hospital

Phase 3 Active not recruiting
1,600 enrolled
Breast

Operable Breast Cancer

NCT02647385 2024-10-08

Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation

Hospital Sirio-Libanes

Phase NA Active not recruiting
50 enrolled
Breast

Agnosia, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡